Provectus Biopharmaceuticals
0 followers
‌
Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer, and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.
Industries
Headquarters
Employees
Links
Org chart
Tim Scott
Collapse
Bruce Horowitz
Chief Operating Officer
Eric Wachter
Chief Technology Officer
Heather Raines
Chief Financial Officer
